Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...

With the US debut of its brand-new system, Aquablu BOLD, at CES 2026, the company is leading the way for AI-driven water ...

The experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, ...

For a section of Gurugram and Delhi-NCR residents, the memories of visiting the live theatre shows of the Kingdom of Dreams ...

New research from MergersandAcquisitions.net examines deal activity, valuation dynamics, and buyer behavior shaping the future of telehealth services ...

Several high-profile big condominium projects in Saskatoon remain stalled or uncertain, but apartment buildings are rising, ...

A data centre-driven memory chip shortage is forcing some suppliers to accept price hikes of over 100% Read more at The Business Times.

If Trump believes that simply taking control of Venezuela is going to be a walk in the park, he would be sorely mistaken.

The so-called "corridor whispers" project was developed by researchers Louis Autin and Eloïse Letellier-Taillefer of the Sorbonne University in Paris and Marie-Adeline Le Guennec of Quebec University, ...